The upcoming report from CVS Health (CVS) is expected to reveal quarterly earnings of $1.69 per share, indicating a decline of 23.2% compared to the year-ago period. Analysts forecast revenues of $89.22 billion, representing an increase of 4.6% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 0.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timef ...

CVS Health (CVS) closed the latest trading day at $67.33, indicating a -0.65% change from the previous session's end. The stock's performance was behind the S&P 500's daily loss of 0.46%. Meanwhile, the Dow lost 0.98%, and the Nasdaq, a tech-heavy index, lost 0.64%.Prior to today's trading, shares of the drugstore chain and pharmacy benefits manager had lost 14.68% over the past month. This has lagged the Retail-Wholesale sector's loss of 3.05% and the S&P 500's loss of 3.04% in that time.The upcoming earni ...

Staff specialists to provide comprehensive skills training and job placement, as well as wraparound health care services BATON ROUGE, La., April 25, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the opening of a new workforce development and community resource center designed to help the Baton Rouge community overcome employment barriers and increase access to local health care services. CVS Health opens new facility to help the Baton Rouge community overcome employment barriers and increa ...

BOCA RATON, Fla., April 23, 2024 /PRNewswire/ -- Baum Family Investments (BFI) proudly announces its official debut in the real estate investment landscape. With over fifteen years of expertise in triple net leased investments and the backing of prominent family offices in Detroit, Miami, and New York, BFI enters the market poised for success. Led by Aaron Baum, a seasoned investor and capital manager with a track record of advising, brokering, and acquiring over $175,000,0000 in net leased real estate nati ...

sturti/E+ via Getty ImagesMedicare Advantage headwind CVS Health Corporation (NYSE:CVS) has been facing some pretty strong headwinds recently. More specifically, the following chart shows the investment returns from CVS stock with a comparison against the broader market (approximated by SPY). On a year-to-date basis, CVS stock has underperformed by a large margin both in absolute and relative terms. It suffered a loss of more than 10% year-to-date, while SPY delivered a total return of 4.5%. Seeking Al ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about CVS Health (CVS) .CVS Health currently has an average brokerage recommenda ...

股价表现 - CVS Health (CVS) 最近的股价为 $69.75，较前一个交易日上涨了 +0.52% [1] - CVS Health 过去一个月的股价下跌了 11.35%，表现不如零售-批发行业的下跌幅度为 2.7% 和标普500指数的下跌幅度为 2.57% [2] 财务预测 - 预计 CVS Health 将在 2024 年 5 月 1 日公布每股收益为 $1.69，较去年同期下降了 23.18%。同时，最新的共识预测显示公司预计营收为 $89.23 亿美元，较去年同期上涨了 4.63% [3] - CVS 的全年 Zacks 共识预测显示每股收益为 $8.32，营收为 $370.61 亿美元。这些结果将分别较去年同期变化为 -4.81% 和 +3.59% [4] 分析师观点 - 最近分析师对 CVS Health 的预测发生了变化，这些变化反映了短期业务趋势的演变。因此，积极的预测修订反映了分析师对公司业务和盈利能力的乐观态度 [5] - 研究表明，这些预测调整直接与即将到来的股价表现相关。为了利用这一点，我们制定了 Zacks Rank，这是一个包括这些预测变化并提供可行评级系统的定量模型 [6] 估值和行业排名 - 从估值角度看，CVS Health 的前瞻市盈率为 8.34，相对于同行业平均前瞻市盈率为 5.45，CVS Health 有溢价 [8] - CVS 的 PEG 比率为 0.92，低于零售-药店和药品店行业的平均 PEG 比率为 1.01 [9] - 零售-药店和药品店行业属于零售-批发行业，目前的 Zacks 行业排名为 238，位于所有行业中的倒数 6% [10]

股价表现 - CVS Health (CVS)最近的股价为$69.39，较前一个交易日上涨了+1.15%[1] - CVS Health的股价在过去一个月下跌了13.14%，落后于零售-批发行业的下跌幅度为2.01%和标普500指数的1.66%[2] 财报预测 - 投资界将密切关注CVS Health在即将发布的财报中的表现。公司计划于2024年5月1日发布财报，预计每股收益为$1.69，同比下降23.18%[3] 营收预估 - Zacks Consensus Estimate预计CVS Health的营收为892.3亿美元，比去年同期增长4.63%[4]

股价表现 - CVS Health (CVS) 最近的股价为 $68.64，较前一交易日收盘价下跌了 -1.58% [1] - CVS Health 近一个月来股价下跌了 8.74%，而同期零售-批发行业上涨了 2.17% [2] 财务预测 - 分析师预计 CVS Health 将在 2024 年 5 月 1 日发布的财报中每股盈利为 $1.69，同比下降了 23.18% [3] - Zacks Consensus Estimates 预测 CVS Health 整个财年每股盈利为 $8.33，营收为 $370.61 亿美元，分别较去年变化了 -4.69% 和 +3.59% [4] 评级和指标 - CVS Health 目前的 Zacks Rank 为 4 (Sell)，最近一个月 Zacks Consensus EPS 估计下调了 0.01% [7] - CVS Health 目前的 Forward P/E ratio 为 8.38，高于行业平均值 5.59 [8] - CVS 目前的 PEG ratio 为 0.92，低于行业平均值 1.02 [9] 行业排名 - Retail - Pharmacies and Drug Stores 行业属于零售-批发行业，该行业的 Zacks Industry Rank 为 245，位于所有 250+ 行业的倒数 3% [10] - Zacks Industry Rank 评估了各行业群体的实力，研究显示排名前 50% 的行业的表现是排名后 50% 的两倍 [11]

股价表现 - CVS Health (CVS) 最新收盘价为 $73.36，较前一天下跌了 1.45% [1] - CVS Health 过去一个月的股价下跌了 1.98%，表现不如零售-批发行业的涨幅 1.12% 和标普500指数的涨幅 1.65% [2] 财务预期 - 投资界将密切关注 CVS Health 即将发布的财报，分析师预计每股收益为 $1.69，同比下降 23.18%，预计营收为 $89.33 亿美元，同比增长 4.75% [3] - Zacks Consensus Estimates 预测 CVS Health 整个财年每股收益为 $8.33，营收为 $370.61 亿美元，分别较去年变化为 -4.69% 和 +3.59% [4] 估值评级 - 近期分析师对 CVS Health 的估值预期发生变化，这通常意味着近期业务趋势的变化，乐观的估值变化表明分析师对公司的业务健康和盈利能力持乐观态度 [5] - Zacks Rank 系统从 1 (强烈买入) 到 5 (强烈卖出)，自 1988 年以来，排名为 1 的股票年均回报率为 +25%，CVS Health 目前的 Zacks Rank 为 3 (持有) [7] 行业比较 - CVS Health 目前的前瞻市盈率为 8.94，较同行业平均前瞻市盈率 5.93 有溢价 [8] - CVS 目前的 PEG 比率为 0.98，该指标类似于市盈率，但还考虑了公司的预期盈利增长率，零售-药店和药品店行业的平均 PEG 比率为 1.09 [9] 行业评级 - 零售-药店和药品店行业属于零售-批发行业，该行业的 Zacks Industry Rank 为 235，位于所有 250+ 行业的倒数 7% [10] - Zacks Industry Rank 通过计算组内个别股票的平均 Zacks Rank 来评估特定行业群体的活力，研究显示，排名前 50% 的行业胜过后 50% 的行业 2 倍 [11] 数据跟踪 - 使用 Zacks.com 跟踪所有这些影响股价的指标，并在即将到来的交易中使用 [12]